Target intelligence / Profile preview

Ankyrin repeat and SOCS box protein 9 (ASB9)

Target
ASB9
Molecular classification
E3 ubiquitin ligase component, Adaptor protein, Ankyrin repeat protein, SOCS box protein, Other
01

Overview

Ankyrin repeat and SOCS box protein 9 (ASB9) is a substrate-recognition component of the Cullin-RING E3 ubiquitin ligase complex, specifically the Elongin-Cullin-SOCS box-type (ECS/CRL5) E3 ligase. It contains an N-terminal intrinsically disordered region, an ankyrin repeat domain that binds substrate proteins, and a C-terminal SOCS box that mediates complex formation with Elongin B/C and Cullin 5. ASB9 binds to creatine kinase with high affinity, targeting it for ubiquitination and subsequent proteasomal degradation, which has roles in energy metabolism, cellular homeostasis, and possibly reproductive physiology[1][2][7][8]. There is currently no evidence of approved therapeutic drugs explicitly targeting ASB9, but its function as a molecular adaptor implicates it in pathways fundamental to cell function and disease.

Other names
Ankyrin repeat and SOCS box containing 9ASB-9DKFZP564L0862MGC4954FLJ20636ankyrin repeat and suppressor of cytokine signaling box protein 9testis tissue sperm-binding protein Li 57p
02

Mechanism of action

Ubiquitination of target proteins (e.g., creatine kinase) leading to their proteasomal degradation

03

Biological functions

Ubiquitination and proteasomal degradationSubstrate recognition for E3 ligase complexProtein modificationRegulation of creatine kinase activityCell signaling modulationPotential regulation of ovarian granulosa cell function and MAPK signaling
04

Disease associations

Metabolic regulation (indirect via creatine kinase turnover)Reproductive biology (ovarian function)Potential link to diseases involving protein homeostasis (e.g., neurodegeneration, cardiac disease)—based on substrate role, not direct evidence
05

Safety considerations

Targeting could impact energy metabolism via creatine kinase turnoverPotential for off-target protein degradation due to substrate adaptor roleEffects on reproductive tissues are possible

Beyond the preview

Go deeper on Ankyrin repeat and SOCS box protein 9 (ASB9).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ankyrin repeat and SOCS box protein 9 (ASB9).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call